Terms: = Head and neck cancer AND ER, estrogen receptor AND Clinical Outcome
25 results:
1. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract] [Full Text] [Related]
2. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract] [Full Text] [Related]
3. estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
Takano EA; Younes MM; Meehan K; Spalding L; Yan M; Allan P; Fox SB; Redfern A; Clouston D; Giles GG; Christie EL; Anderson RL; Zethoven M; Phillips KA; Gorringe K; Britt KL
BMC Cancer; 2023 May; 23(1):459. PubMed ID: 37208678
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of factors influencing the clinical outcome after surgery and
Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
[TBL] [Abstract] [Full Text] [Related]
5. Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy.
Rong C; Grünow J; Thierauf J; Lucena-Porcel C; Major G; Holzinger D; Dyckhoff G; Kern J; Lammert A; Scherl C; Rotter N; Plinkert PK; Affolter A
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856431
[TBL] [Abstract] [Full Text] [Related]
6. Potential Impact of Body Mass Index on the clinical outcome of Papillary Thyroid cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract] [Full Text] [Related]
7. Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion.
Sato D; Kadota T; Inaba A; Nishihara K; Takashima K; Nakajo K; Sawada K; Kotani D; Fujiwara H; Yoda Y; Kojima T; Fujita T; Fujii S; Yano T
Gastrointest Endosc; 2022 Apr; 95(4):634-641.e3. PubMed ID: 34774578
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant expression of Sec61α in esophageal cancers.
Bachmann K; Bockhorn M; Mann O; Gebauer F; Blessmann M; Izbicki JR; Grupp K
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2039-2044. PubMed ID: 31197453
[TBL] [Abstract] [Full Text] [Related]
9. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.
Chang CW; Chen YS; Tsay YG; Han CL; Chen YJ; Yang CC; Hung KF; Lin CH; Huang TY; Kao SY; Lee TC; Lo JF
Cell Death Dis; 2018 Feb; 9(2):194. PubMed ID: 29416012
[TBL] [Abstract] [Full Text] [Related]
10. Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid cancer.
Li H; Zhang YQ; Wang C; Zhang X; Li X; Lin YS
Clin Endocrinol (Oxf); 2018 Apr; 88(4):601-606. PubMed ID: 29338092
[TBL] [Abstract] [Full Text] [Related]
11. Type of surgical treatment and recurrence of oral leukoplakia: A retrospective clinical study.
Monteiro L; Barbieri C; Warnakulasuriya S; Martins M; Salazar F; Pacheco JJ; Vescovi P; Meleti M
Med Oral Patol Oral Cir Bucal; 2017 Sep; 22(5):e520-e526. PubMed ID: 28809365
[TBL] [Abstract] [Full Text] [Related]
12. clinical outcome of Radioiodine Therapy in Low-intermediate Risk Papillary Thyroid Carcinoma with BRAF(V600E) Mutation.
Li J; Yang T; Zhao T; Liang J; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):346-50. PubMed ID: 27544995
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome of (131)I Therapy in Differentiated Thyroid cancer with Preablative Thyroglobulin below 10 ng/ml.
Liu XF; Li J; Zhao T; Hou M; Li H; Liang J; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):88-92. PubMed ID: 26956863
[TBL] [Abstract] [Full Text] [Related]
14. Osteoradionecrosis of the Posterior Maxilla: A New Approach Combining Erbium: Yttrium Aluminium Garnet Laser and Bichat Bulla Flap.
Porcaro G; Amosso E; Mirabelli L; Busa A; Carini F; Maddalone M
J Craniofac Surg; 2015 Oct; 26(7):e627-9. PubMed ID: 26468848
[TBL] [Abstract] [Full Text] [Related]
15. ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma.
Yeo SY; Ha SY; Yu EJ; Lee KW; Kim JH; Kim SH
Oncotarget; 2014 Dec; 5(23):12260-72. PubMed ID: 25373738
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients.
Zhou SW; Su BB; Zhou Y; Feng YQ; Guo Y; Wang YX; Qi P; Xu S
Med Oncol; 2014 Nov; 31(11):259. PubMed ID: 25270284
[TBL] [Abstract] [Full Text] [Related]
17. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
[TBL] [Abstract] [Full Text] [Related]
18. clinical and surgical management of odontoma.
Angiero F; Benedicenti S; Parker S; Signore A; Sorrenti E; Giacometti E; Crippa R
Photomed Laser Surg; 2014 Jan; 32(1):47-53. PubMed ID: 24393004
[TBL] [Abstract] [Full Text] [Related]
19. estrogen receptor α and β in esophageal squamous cell carcinoma.
Zuguchi M; Miki Y; Onodera Y; Fujishima F; Takeyama D; Okamoto H; Miyata G; Sato A; Satomi S; Sasano H
Cancer Sci; 2012 Jul; 103(7):1348-55. PubMed ID: 22463081
[TBL] [Abstract] [Full Text] [Related]
20. Probing the link between oestrogen receptors and oesophageal cancer.
Rashid F; Khan RN; Iftikhar SY
World J Surg Oncol; 2010 Feb; 8():9. PubMed ID: 20146809
[TBL] [Abstract] [Full Text] [Related]
[Next]
